Antimicrobial Agents and Chemotherapy · 2023 · 14 citations · 21 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceAntibacterial AgentsAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistancePulmonary InfectionsBactericidal AgentsRifabutin-based Therapy
ABSTRACT Necrotic lesions and cavities filled with caseum are a hallmark of mycobacterial pulmonary disease. Bronchocavitary Mycobacterium abscessus disease is associated with poor treatment outcomes. In caseum surrogate, M. abscessus entered an extended stationary phase showing tolerance to killing by most current antibiotics, suggesting that caseum persisters contribute to the poor performance of available treatments. Novel ADP-ribosylation-resistant rifabutin analogs exhibited bactericidal activity against these M. abscessus persisters at concentrations achievable by rifamycins in caseum.
21
Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
Jansy P. Sarathy, Laura E. Via, Landry Blanc et al. · Antimicrobial Agents and Chemotherapy · 2017 · 237 citations · Full text